№ lp_1_2_64872
File format: docx
Character count: 3373
File size: 133 KB
Clinical guideline document outlining maximum recommended daily opioid doses, assessment procedures, and safety measures for managing non-cancer pain in general practice.
Year:
2019
Organization:
The Royal Australian College of General Practitioners (RACGP)
Document type:
Policy template
Purpose:
Safe limitations for prescribing opioid medication
Scope:
Non-malignant pain
Current as of:
[insert date of last revision]
Version no:
[insert version number]
Review date:
[insert date]
Target audience:
General practitioners
Source:
RACGP Clinical Governance Framework
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2025
Region / City:
Aotearoa
Topic:
Ondansetron usage, dosing guidelines, drug interactions
Document Type:
Medical Best Practice Guide
Organization / Institution:
HealthPathways, Health New Zealand, Te Whatu Ora
Author:
Riani Albertyn, Brendan Duck
Target Audience:
Healthcare professionals
Period of Validity:
2025
Approval Date:
March 2025
Date of Changes:
January 2024
Year:
2024
Region / City:
South-East Queensland
Topic:
Water treatment, chemical dosing units
Document Type:
Technical Specification
Organization:
Urban Utilities
Author:
Santhosh Jambagi
Target Audience:
Designers, constructors, and stakeholders involved in chemical dosing systems for water infrastructure
Period of Validity:
From 31/10/2024
Approval Date:
31/10/2024
Date of Revision:
31/10/2024
Year:
2013
Region / city:
United States
Topic:
Clinical guidelines for vancomycin dosing and management
Document type:
Clinical Protocol
Organization / Institution:
UConn Health – John Dempsey Hospital
Author:
Director of Pharmacy, Dept. of Infectious Diseases
Target audience:
Licensed Prescribers, Pharmacists, Nurses
Period of validity:
Ongoing
Approval date:
10/30/13
Last revision date:
10/2020
Year:
2019
Region / city:
UConn Health – John Dempsey Hospital
Theme:
Clinical Practice
Document Type:
Protocol
Organization / institution:
UConn Health, Department of Pharmacy, Department of Infectious Diseases
Author:
John Dempsey Hospital Pharmacy Department
Target audience:
Licensed Prescribers, Pharmacists, Nurses
Effective Period:
Not specified
Approval Date:
1/9/19
Date of Last Revision:
Not specified
Date Retired:
Not specified
Year:
2024
Date:
August 19, 2024
Location:
Adventist Health Glendale Hospital, 1509 Wilson Terrace, Glendale, CA 91206
Venue:
Wu Auditorium, East Tower, Ground Floor
Organizing Body:
SGVSHP
Speaker:
Jignesh H. Patel, Pharm.D., B.Sc.
Affiliation:
Western University of Health Sciences, College of Pharmacy
Department:
Pharmacy Practice and Administration
Target Audience:
Pharmacists, Technicians
Activity Type:
Knowledge-based Continuing Education
Continuing Education Credit:
Available
CE Fee:
No charge for CSHP members
Time:
6:30 PM – 8:00 PM PST
Dinner:
5:30 PM – 6:30 PM
Contact Persons:
Duc Bach; Lisa Gunther
RSVP Deadline:
August 16, 2024
Year:
2026
Region / City:
Ohio
Topic:
Pediatric Drug Dosing, Infantile Spasms
Document Type:
Medical Response
Organization:
The Ohio State University College of Pharmacy
Author:
Hailey Baird
Target Audience:
Medical Professionals, Pediatric Neurologists
Period of Effectiveness:
2026
Approval Date:
2026
Date of Last Update:
2026
Year:
2026
Institution:
Royal Infirmary of Edinburgh
Department:
Renal Directorate
Document Type:
Clinical guideline
Intended Audience:
Healthcare professionals in nephrology and dialysis units
Indication:
Prevention of clotting in extracorporeal haemodialysis circuits
Dosage Information:
Weight-based Dalteparin administration at start of dialysis
Monitoring:
Anti-Xa levels at 1 and 4 hours post-administration under specific conditions
Contraindications:
Systemic anticoagulation, invasive procedures within 24 hours, hypersensitivity to heparin or LMWHs, haemophilia, severe thrombocytopenia, recent cerebral haemorrhage, severe liver disease, acute peptic ulceration
Side Effects:
Skin rashes, minor bruising, systemic allergic reactions, excessive bleeding, thrombocytopenia, skin necrosis, hyperkalaemia
Reversal:
Protamine sulphate if severe bleeding occurs during or within 2 hours post-dialysis
Year:
Not specified
Region / City:
Not specified
Topic:
Mistletoe therapy dosing
Document type:
Medical Guide
Organization / Institution:
Not specified
Author:
Not specified
Target audience:
Patients receiving mistletoe therapy
Duration:
Long-term therapy
Approval date:
Not specified
Modification date:
Not specified
Year:
2020
Region / City:
North Carolina
Topic:
Procurement standards, Federal funding, Micro-purchase threshold
Document type:
Informational Guide
Organization:
Office of Management and Budget (OMB)
Author:
Not specified
Target audience:
Local government units in North Carolina
Effective date:
August 13, 2020
Date of approval:
Not specified
Date of revisions:
Not specified
Year:
2019
Region / City:
California
Theme:
Privacy, Data Protection
Document Type:
Policy
Agency / Institution:
Office of Information Security
Author:
Office of Information Security
Target Audience:
Government entities, privacy coordinators, system owners, project managers
Period of validity:
Not specified
Approval Date:
September 2019
Last Review Date:
July 2024
Amendment Date:
June 2022, September 2022, June 2024
Year:
2024
Region / City:
North East Lincolnshire
Theme:
Online Safety, Child Protection
Document Type:
Guidance
Institution:
North East Lincolnshire
Author:
Unknown
Target Audience:
Professionals working with children, Parents, Caregivers
Period of Validity:
2024-2028
Approval Date:
May 2024
Amendment Date:
May 2025
Year:
2022
Region / City:
European Union
Topic:
Financial regulations, EU parent institutions, third country branches
Document Type:
Guidelines
Organization / Institution:
European Banking Authority (EBA)
Author:
European Banking Authority (EBA)
Target Audience:
Competent authorities, EU parent institutions, third-country groups
Effective Period:
Ongoing, annual assessments
Approval Date:
May 2022
Date of Changes:
N/A
Year:
2023
Region / City:
United States
Topic:
Privacy Impact Assessment
Document Type:
Template
Agency / Institution:
Federal Risk and Authorization Management Program (FedRAMP)
Author:
FedRAMP Team
Target Audience:
Federal agencies, Cloud Service Providers (CSPs)
Period of Validity:
Ongoing
Approval Date:
Month DD, YYYY
Date of Changes:
None
Year:
2026
Region / City:
United States
Topic:
IRS Reporting Threshold Changes for Research Payments
Document Type:
Information Sheet
Organization:
Hennepin Healthcare
Author:
Hennepin Healthcare PI
Target Audience:
Research Study Participants
Effective Date:
January 1, 2026
Date of Issue:
30 JAN 2026
Year:
2024
Region/City:
New Mexico
Theme:
Homelessness Assistance, Housing Programs
Document Type:
RFP (Request for Proposal)
Organization:
Housing New Mexico | MFA
Author:
Unknown
Target Audience:
Non-profit organizations, local governments, and tribal governments
Period of Validity:
2024
Approval Date:
Unknown
Date of Changes:
Unknown
Year:
2019
Region / city:
Queensland
Topic:
Ethical supplier compliance
Document type:
Declaration form
Organization / institution:
Queensland Government
Author:
Queensland Government
Target audience:
Suppliers responding to tenders
Validity period:
From 1 August 2019
Approval date:
1 August 2019
Changes date:
Not specified
Compliance information disclosure consent:
Yes
Note:
Context description
Date:
March 18, 2021
Document Type:
Memorandum
Subject:
Use of Other Than Full and Open Competition for an Acquisition Under the Simplified Acquisition Threshold
Reference:
FAR 13.106-1(b)(1)(i); FAR 13.106-3(b)(3)(i)
Regulatory Framework:
Federal Acquisition Regulation (FAR)
Acquisition Threshold:
Simplified Acquisition Threshold
Item or Service:
Magazine Sprinkler Valve Kits and replacement/rebuild parts for control valves
Manufacturer:
MONTREAL BRONZE FOUNDRY LTD
Model Numbers:
U-07BAA-3E01-443A; U-07BAA-3E01-443; U-10BAA-3E01-443A; U-10BAA-3E01-443; U-14BAA-3E01-443; U-15BAA-3E01-443; U-15BAA-3E01-443M
Delivery Date:
July 1, 2021
Purpose:
Replacement of old parts to support valve overhaul
System:
Magazine Sprinkler System (Fire Protection System)
Justification Basis:
Only One Responsible Source; Restrictive Rights; Critical Ship Equipment; Standardization/Brand Name; Form, Fit, and Function
Proprietary Rights Holder:
MONTREAL BRONZE FOUNDRY LTD
Identified Vendors:
Valve Automation and Controls; W&O Supply; Hawk Valve, INC
Associated Vessels:
USNS WILLIAM MCLEAN; USNS MEDGAR EVERS; USNS CESAR CHAVEZ
Procedure Reference:
SMS Procedure Number 10.6-002-ALL
Anticipated Dollar Value:
Not specified
Certifications:
Technical/Requirement Certification; Contract Specialist; Contracting Officer; Higher-Level Approval
Year:
2023
Region / city:
Cambridgeshire and Peterborough
Theme:
Smoking cessation, healthcare policy, surgery
Document type:
Policy
Organization:
NHS
Author:
Not specified
Target audience:
Healthcare professionals, general practitioners
Period of validity:
Not specified
Approval date:
Not specified
Amendment date:
Not specified
Referral options:
Stop Smoking Service, self-referral, GP referral
Intended outcome:
Reduction in surgical complications related to smoking
Relevant guidance:
NICE NG209, NICE PH66, British Thoracic Society
Website for additional information:
Healthyyou stop-smoking web site
Telephone:
0333 005 0093
Email:
[email protected]
Note:
Description
Year:
2014
Organization:
American Conference of Governmental Industrial Hygienists (ACGIH)
Chemical:
n-propyl bromide (1-bromopropane)
Flash Point:
21°C
TLV (Threshold Limit Value):
0.1ppm
Industry:
Industrial Hygiene
Document Type:
Scientific Publication
Target Audience:
Industrial hygienists, chemical professionals
Legal Issue:
IBSA et al. v. ACGIH lawsuit
Additional Information:
nPB contamination <0.01% iPB